Implications of biochemical, cytokinetic, pharmacologic, and toxicologic relationships in the design of optimal therapeutic schedules

Cancer Chemother Rep. 1970 Dec;54(6):431-50.
No abstract available

MeSH terms

  • Animals
  • Antineoplastic Agents / administration & dosage*
  • Antineoplastic Agents / blood
  • Antineoplastic Agents / toxicity
  • Cyclophosphamide / administration & dosage
  • Cytarabine / administration & dosage
  • DNA, Neoplasm / biosynthesis
  • Dactinomycin / administration & dosage
  • Daunorubicin / administration & dosage
  • Disease Models, Animal
  • Fluorouracil / administration & dosage
  • Half-Life
  • Hydroxyurea / administration & dosage
  • In Vitro Techniques
  • Kinetics
  • Leukemia L1210 / drug therapy*
  • Mercaptopurine / administration & dosage
  • Methotrexate / administration & dosage
  • Mice
  • Mitosis
  • Nitrosourea Compounds / administration & dosage
  • Thiosemicarbazones / administration & dosage

Substances

  • Antineoplastic Agents
  • DNA, Neoplasm
  • Nitrosourea Compounds
  • Thiosemicarbazones
  • Cytarabine
  • Dactinomycin
  • Cyclophosphamide
  • Mercaptopurine
  • Fluorouracil
  • Hydroxyurea
  • Methotrexate
  • Daunorubicin